14th Annual Philip S. Chen, Jr., Ph.D. Distinguished Lecture on Innovation and Technology Transfer
November 8, 2019
|
|
Lightning Chess: The Long and Winding Road Toward Molecular Cures of the First Molecular Disease
Dr. John Tisdale Senior Investigator Chief, Cellular and Molecular Therapeutics National Heart, Lung and Blood Institute
https://videocast.nih.gov/launch.asp?28840
|
|
13th Annual Philip S. Chen, Jr., Ph.D. Distinguished Lecture on Innovation and Technology Transfer
November 2, 2018
|
|
Lightning Chess: How Host Immunity Gains a Winning Position Against
Ebolavirus InfectionNancy Sullivan, PhD Senior Investigator Chief, Biodefense Research Section Vaccine Research Center National Institute of Allergy and Infectious Diseases
https://videocast.nih.gov/launch.asp?26164
|
|
|
12th Annual Philip S. Chen, Jr., Ph.D. Distinguished Lecture on Innovation and Technology Transfer
November 17, 2017
|
|
CELLS AS ANTI-CANCER DRUGS: ENTERING MAINSTREAM ONCOLOGY
Steven A. Rosenberg, M.D., Ph.D. Chief, Surgery Branch and Senior Investigator National Cancer Institute
https://videocast.nih.gov/launch.asp?23596
|
|
|
|
|
11th Annual Philip S. Chen, Jr., Ph.D. Distinguished Lecture on Innovation and Technology Transfer
October 14, 2016
|
|
CYTOKINE SIGNALING: GENES, GENOMES AND DRUGS
John J. O'Shea, M.D.
Scientific Director and Senior Investigator
National Institute of Arthritis and Musculoskeletal and Skin Diseases
|
|
|
|
|
10th Annual Philip S. Chen, Jr., Ph.D. Distinguished Lecture on Innovation and Technology Transfer
October 23, 2015
|
|
UNEXPECTED RESULTS FROM UNCONVENTIONAL APPROACHES TO ADENO-ASSOCIATED VIRUS RESEARCH
Robert M. Kotin, Ph.D.
Senior Investigator (1999–2014) at the National Heart, Lung and Blood Institute;
Vice President of Voyager Therapeutics (2014-2016);
Scientific Founder and Head of Discovery at Generation Bio, and Adjunct Professor at the Gene Therapy Center of the University of Massachusetts Medical School in Worcester
|
|
|
|
|
9th Annual Philip S. Chen, Jr., Ph.D. Distinguished Lecture on Innovation and Technology Transfer
October 3, 2014
|
|
PURINE RECEPTOR DRUGS: FUTURE TREATMENT FOR CHRONIC DISEASES?
Kenneth A. Jacobson, Ph.D.
Chief, Laboratory of Bioorganic Chemistry & Molecular Recognition Section
National Institute of Diabetes & Digestive & Kidney Diseases
|
|
|
|
|
8th Annual Philip S. Chen, Jr., Ph.D. Distinguished Lecture on Innovation and Technology Transfer
November 22, 2013
|
|
TB: IT TAKES MORE THAN A VILLAGE TO RAISE A REMEDY
Clifton E. Barry III, Ph.D.
Chief, Tuberculosis Research Section
National Institute of Allergy and Infectious Diseases
Carol A. Nacy, Ph.D.
Co-Founder and CEO
Sequella, Inc.
|
|
|
7th Annual Philip S. Chen, Jr., Ph.D. Distinguished Lecture on Innovation and Technology Transfer
November 15, 2012
|
|
A MULTIFUNCTIONAL BASEMENT MATRIX FOR NORMAL, CANCER, AND STEM CELLS: THE BME/MATRIGEL STORY
Hynda K. Kleinman, Ph.D.
former Senior Investigator
National Institute of Dental and Craniofacial Research
|
|
|
|
|
6th Annual Philip S. Chen, Jr., Ph.D. Distinguished Lecture on Innovation and Technology Transfer
December 9, 2011
|
|
TREATMENT OF CANCER WITH RECOMBINANT IMMUNOTOXINS: FROM TECHNOLOGY TRANSFER TO THE PATIENT
Ira Pastan, M.D.
Co-Chief, Laboratory of Molecular Biology
Head, Molecular Biology Section
National Cancer Institute
|
|
|
|
|
5th Annual Philip S. Chen, Jr., Ph.D. Distinguished Lecture on Innovation and Technology Transfer
November 5, 2010
|
|
HUMAN RETROVIRUSES: PERSPECTIVES FROM THE PAST, PROSPECTS FOR THE FUTURE
Robert C. Gallo, M.D.
The Homer & Martha Gudelsky Distinguished Professor in Medicine, and
Director, Institute of Human Virology
at the University of Maryland School of Medicine
|
|
|
|
|
4th Annual Philip S. Chen, Jr., Ph.D. Distinguished Lecture on Innovation and Technology Transfer
November 13, 2009
|
|
VIRAL HEPATITIS AND THE NIH: A JAUNDICED VIEW OF HISTORY
Harvey J. Alter, M.D.
Chief, Infectious Disease
Department of Transfusion Medicine
NIH Clinical Center
Robert H. Purcell, M.D.
Co-Chief, Laboratory of Infectious Diseases
National Institute of Allergy and Infectious Diseases
|
|
|
|
|
3rd Annual Philip S. Chen, Jr., Ph.D. Distinguished Lecture on Innovation and Technology Transfer
September 18, 2008
|
|
INNOVATION IN THE IMAGING SCIENCES AT THE NATIONAL INSTITUTES OF HEALTH
Robert S. Balaban, Ph.D.
Director, Division of Intramural Research
National Heart, Lung, and Blood Institute
|
|
|
|
|
2nd Annual Philip S. Chen, Jr., Ph.D. Distinguished Lecture on Innovation and Technology Transfer
January 26, 2007
|
|
THE SCIENCE, TECHNOLOGY AND PROMISE OF PREVENTIVE HPV VACCINES
Douglas R. Lowy, M.D.
Deputy Director, Center for Cancer Research
Chief, Laboratory of Cellular Oncology
National Cancer Institute
|
|
|
|
|
First Annual Philip S. Chen, Jr., Ph.D. Distinguished Lecture on Innovation and Technology Transfer
January 20, 2006
|
|
INNOVATION AND COLLABORATION: REVOLUTIONIZING TB THERAPY
Maria Freire, Ph.D.
CEO & President
Global Alliance for TB Drug Development
|
|
|
|
|
|